Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125206731 | 12520673 | 1 | I | 20160617 | 20160701 | 20160701 | EXP | CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-119333 | RANBAXY | ZOU D-F, ZENG H-W, YU J, MAI H-R, YUAN X-L, WANG L-H ET AL. BRAIN INJURY AFTER INDUCTION CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA. ZHONGGUO DANG DAI ER KE ZA ZHI. 2016;18(3):254-258 | 0.00 | C | Y | 0.00000 | 20160701 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125206731 | 12520673 | 1 | PS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | U | 89247 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125206731 | 12520673 | 1 | Acute lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125206731 | 12520673 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125206731 | 12520673 | Atrophy | |
| 125206731 | 12520673 | Condition aggravated |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |